Premium
Importance of intensive blood pressure control in type 2 diabetes: Mechanisms, treatments and current guidelines
Author(s) -
Marre Michel
Publication year - 2020
Publication title -
diabetes, obesity and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.445
H-Index - 128
eISSN - 1463-1326
pISSN - 1462-8902
DOI - 10.1111/dom.13975
Subject(s) - medicine , blood pressure , diabetes mellitus , calcium channel blocker , observational study , type 2 diabetes , diuretic , cardiology , hemodynamics , diastole , aldosterone , intensive care medicine , endocrinology
Observational and interventional studies have shown that intensified blood pressure (BP) reduction can benefit people with diabetes. Because of their special haemodynamic properties, renin‐angiotensin‐aldosterone system (RAAS) blockers are recommended. The results of the BP arm of the ADVANCE study strongly support the recently updated European Society of Cardiology/European Association of Diabetes recommendations for the treatment of BP in people with diabetes, which recommend a target systolic/diastolic BP of 130/80 mmHg with few exceptions, and a fixed combination of an RAAS blocker with a diuretic or a calcium channel blocker as first‐line treatment.